Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study

OBJECTIVES: An increased risk of mortality in patients with hyperuricemia has been reported. We examined (1) the risk of all-cause and cardiovascular disease (CVD) mortality in untreated hyperuricemic patients who did not receive urate-lowering therapy (ULT), and (2) the impact of ULT on mortality r...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiunn-Horng, Lan, Joung-Liang, Cheng, Chi-Fung, Liang, Wen-Miin, Lin, Hsiao-Yi, Tsay, Gregory J, Yeh, Wen-Ting, Pan, Wen-Harn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684295/
https://www.ncbi.nlm.nih.gov/pubmed/26683302
http://dx.doi.org/10.1371/journal.pone.0145193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684295/
https://www.ncbi.nlm.nih.gov/pubmed/26683302
http://dx.doi.org/10.1371/journal.pone.0145193

Ejemplares similares